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The original article \[[@CR1]\] contains errors in Figs. 4 & 5; Fig. 4A is misaligned and the top-left panel of Fig. 5A mistakenly duplicates the left panel of Fig. 2C in the original manuscript.

The corrected version of both Figs. [4](#Fig1){ref-type="fig"}A and [5](#Fig2){ref-type="fig"}A can be viewed ahead in this correction article. Fig. 4MSX2 deletion promotes upregulation of EHT signature genes. **a** Heatmap of hematopoietic signature genes in CD31^+^ cells derived from H1 WT, H1 MSX2^−/−^ 1\# and 2\# cells. **b** GSEA of hematopoiesis-associated gene sets in CD31^+^ cells derived from H1 WT, H1 MSX2^−/−^ 1\# and 2\# cells. **c** The real-time PCR analysis of *RUNX1*, *GATA2*, *TAL1*, and *GATA1* expression in CD31^+^ cells derived from H1 WT, H1 MSX2^−/−^ 1\# and 2\# cells at day 8 of hematopoietic differentiation. Expression is normalized to the level (= 1) of mRNA in H1 WT cells. **d** ChIP-qPCR analysis of MSX2-responsive elements on promoters of several EHT-associated transcription factors in H1-derived cells. Non-specific IgG was used as isotype control. All values are normalized to that of their corresponding input samples. Results are shown as means ± SD (*n* = 3). NS, not significant; \**P* \< 0.05, \*\**P* \< 0.01, and \*\*\**P* \< 0.001Fig. 5MSX2 mediates the function of TGFβ signaling during EHT. **a** Representative immunofluorescence images of CD43^+^ HPCs (red) generated from H1 WT and H1 MSX2^−/−^ cells with or without SB treatment. Nuclei were stained with DAPI (blue). **b** Upper panel: Flow cytometry analysis showing the percentage of CD43^+^ cells from H1 WT and H1 MSX2^−/−^ cells with or without SB treatment at day 8 of hematopoietic differentiation. Lower panel: The fold increase of CD43^+^ cell generation from H1 WT and H1 MSX2^−/−^ cells after SB treatment. **c** Representative flow cytometry dot plots showing the generation of CD43^+^ subpopulation gated on CD31^+^ cells from H1 WT and H1 MSX2^−/−^ cells at day 8 of hematopoietic differentiation with or without SB treatment. **d** Flow cytometry analysis showing the percentage of CD43^+^ subpopulation gated on CD31^+^ cells from H1 WT and H1 MSX2^−/−^ cells at day 8 of hematopoietic differentiation with or without SB treatment. The fold increase is also shown (lower panel). Results are shown as means ± SD (*n* = 3). NS, not significant; \**P* \< 0.05 and \*\**P* \< 0.01
